Log In
Print
BCIQ
Print
Print this Print this
 

pritelivir (AIC316)

  Manage Alerts
Collapse Summary General Information
Company AiCuris GmbH & Co. KG
DescriptionHelicase-primase inhibitor against herpes simplex virus Type 1 (HSV-1) and HSV-2
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase II
IndicationHerpes simplex virus (HSV)
Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today